A detailed history of California Public Employees Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, California Public Employees Retirement System holds 967,851 shares of VRTX stock, worth $395 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
967,851
Previous 1,012,058 4.37%
Holding current value
$395 Million
Previous $474 Million 5.11%
% of portfolio
0.32%
Previous 0.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $20.3 Million - $22.4 Million
-44,207 Reduced 4.37%
967,851 $450 Million
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $66.1 Million - $81.7 Million
-168,295 Reduced 14.26%
1,012,058 $474 Million
Q1 2024

Apr 30, 2024

SELL
$407.69 - $446.08 $137 Million - $150 Million
-335,463 Reduced 22.13%
1,180,353 $493 Million
Q4 2023

Feb 01, 2024

BUY
$343.0 - $410.68 $2.01 Million - $2.4 Million
5,855 Added 0.39%
1,515,816 $617 Million
Q3 2023

Nov 02, 2023

BUY
$338.18 - $362.46 $14.3 Million - $15.3 Million
42,343 Added 2.89%
1,509,961 $525 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $3.81 Million - $4.27 Million
-12,127 Reduced 0.82%
1,467,618 $516 Million
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $19.3 Million - $22.1 Million
-68,292 Reduced 4.41%
1,479,745 $466 Million
Q4 2022

Feb 08, 2023

SELL
$285.76 - $321.48 $72 Million - $81 Million
-251,831 Reduced 13.99%
1,548,037 $447 Million
Q3 2022

Nov 09, 2022

SELL
$273.83 - $305.53 $21.1 Million - $23.6 Million
-77,220 Reduced 4.11%
1,799,868 $521 Million
Q2 2022

Aug 10, 2022

SELL
$234.96 - $292.55 $5.98 Million - $7.45 Million
-25,463 Reduced 1.34%
1,877,088 $529 Million
Q1 2022

May 04, 2022

SELL
$221.42 - $260.97 $8.03 Million - $9.46 Million
-36,268 Reduced 1.87%
1,902,551 $497 Million
Q4 2021

Feb 10, 2022

SELL
$177.01 - $223.45 $11.9 Million - $15.1 Million
-67,499 Reduced 3.36%
1,938,819 $426 Million
Q3 2021

Nov 10, 2021

BUY
$181.39 - $202.99 $2.16 Million - $2.42 Million
11,900 Added 0.6%
2,006,318 $364 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $2.72 Million - $3.2 Million
-14,495 Reduced 0.72%
1,994,418 $402 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $20.6 Million - $24 Million
-99,555 Reduced 4.72%
2,008,913 $432 Million
Q4 2020

Feb 02, 2021

SELL
$207.01 - $276.09 $10.9 Million - $14.6 Million
-52,776 Reduced 2.44%
2,108,468 $498 Million
Q3 2020

Nov 05, 2020

SELL
$255.65 - $303.1 $4.62 Million - $5.48 Million
-18,080 Reduced 0.83%
2,161,244 $588 Million
Q2 2020

Aug 12, 2020

BUY
$225.48 - $295.8 $360 Million - $472 Million
1,596,444 Added 273.89%
2,179,324 $633 Million
Q1 2020

May 12, 2020

SELL
$199.77 - $247.81 $4.61 Million - $5.72 Million
-23,089 Reduced 3.81%
582,880 $139 Million
Q4 2019

Jan 27, 2020

BUY
$166.71 - $223.91 $10.1 Million - $13.6 Million
60,781 Added 11.15%
605,969 $133 Million
Q3 2019

Oct 31, 2019

BUY
$166.23 - $187.09 $25.6 Million - $28.8 Million
153,979 Added 39.36%
545,188 $92.4 Million
Q2 2019

Aug 15, 2019

SELL
$164.61 - $190.37 $1.78 Million - $2.06 Million
-10,796 Reduced 2.69%
391,209 $71.7 Million
Q1 2019

May 03, 2019

SELL
$163.73 - $194.7 $1.29 Million - $1.54 Million
-7,903 Reduced 1.93%
402,005 $73.9 Million
Q4 2018

Feb 08, 2019

SELL
$151.91 - $192.21 $4.75 Million - $6.01 Million
-31,292 Reduced 7.09%
409,908 $67.9 Million
Q3 2018

Nov 13, 2018

SELL
$167.73 - $192.74 $5.95 Million - $6.83 Million
-35,455 Reduced 7.44%
441,200 $85 Million
Q2 2018

Aug 15, 2018

SELL
$145.72 - $169.96 $8.85 Million - $10.3 Million
-60,706 Reduced 11.3%
476,655 $81 Million
Q1 2018

May 11, 2018

SELL
$151.6 - $177.13 $6.95 Million - $8.13 Million
-45,876 Reduced 7.87%
537,361 $87.6 Million
Q4 2017

Feb 06, 2018

BUY
$137.28 - $155.55 $9.89 Million - $11.2 Million
72,019 Added 14.09%
583,237 $87.4 Million
Q3 2017

Nov 15, 2017

BUY
$148.13 - $162.24 $75.7 Million - $82.9 Million
511,218
511,218 $77.7 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.